Subscribe To
The ratings game: these home builder stocks are a sell as inflation concerns trump upbeat home construction data
Shares of home builders fell Wednesday, despite upbeat new-home construction data, after KeyBanc Capital analyst Kenneth Zener ...
January 19, 2022, 2:40 pm
The ratings game: these home builder stocks are a sell as inflation concerns trump upbeat home construction data
Shares of home builders fell Wednesday, despite upbeat new-home construction data, after KeyBanc Capital analyst Kenneth Zener ...
January 19, 2022, 2:40 pm
The ratings game: these home builder stocks are a sell as inflation concerns trump upbeat home construction data
Shares of home builders fell Wednesday, despite upbeat new-home construction data, after KeyBanc Capital analyst Kenneth Zener ...
January 19, 2022, 2:40 pm
3 stocks with solid financial strength
Benjamin Graham, the father of value investing, recommended investors to look for stocks that have a cu...
December 30, 2021, 1:04 pm
3 stocks with solid financial strength
Benjamin Graham, the father of value investing, recommended investors to look for stocks that have a cu...
December 30, 2021, 1:04 pm
3 stocks with solid financial strength
Benjamin Graham, the father of value investing, recommended investors to look for stocks that have a cu...
December 30, 2021, 1:04 pm
Redhill biopharma's talicia recommended for h. pylori infection
RedHill Biopharma Ltd (NASDAQ: RDHL) has announced the publication of a new study revealing concerning rates of widespread, physician-directed pres...
December 9, 2021, 1:05 pm
Redhill biopharma's talicia recommended for h. pylori infection
RedHill Biopharma Ltd (NASDAQ: RDHL) has announced the publication of a new study revealing concerning rates of widespread, physician-directed pres...
December 9, 2021, 1:05 pm
Redhill biopharma's talicia recommended for h. pylori infection
RedHill Biopharma Ltd (NASDAQ: RDHL) has announced the publication of a new study revealing concerning rates of widespread, physician-directed pres...
December 9, 2021, 1:05 pm
Are biogen or zimmer biomet recommended buys? #askhalftime
The "Halftime Report" traders answer viewer questions in #AskHalftime. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https:/...
December 8, 2021, 1:40 pm
Are biogen or zimmer biomet recommended buys? #askhalftime
The "Halftime Report" traders answer viewer questions in #AskHalftime. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https:/...
December 8, 2021, 1:40 pm
Are biogen or zimmer biomet recommended buys? #askhalftime
The "Halftime Report" traders answer viewer questions in #AskHalftime. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https:/...
December 8, 2021, 1:40 pm
The ratings game: citrix systems stock slides toward 2-year low after ‘sudden' ceo departure prompts citigroup downgrade
Shares of Citrix Systems Inc. slid toward a two-year low Friday, after Citigroup recommended that inves...
October 8, 2021, 2:21 pm
The ratings game: citrix systems stock slides toward 2-year low after ‘sudden' ceo departure prompts citigroup downgrade
Shares of Citrix Systems Inc. slid toward a two-year low Friday, after Citigroup recommended that inves...
October 8, 2021, 2:21 pm
The ratings game: citrix systems stock slides toward 2-year low after ‘sudden' ceo departure prompts citigroup downgrade
Shares of Citrix Systems Inc. slid toward a two-year low Friday, after Citigroup recommended that inves...
October 8, 2021, 2:21 pm
Gsk gets who recommendation for roll-out of malaria vaccine
The World Health Organisation (WHO) has recommended the use of GlaxoSmithKline's malaria vaccine in chi...
October 7, 2021, 9:08 am
Gsk gets who recommendation for roll-out of malaria vaccine
The World Health Organisation (WHO) has recommended the use of GlaxoSmithKline's malaria vaccine in chi...
October 7, 2021, 9:08 am
Gsk gets who recommendation for roll-out of malaria vaccine
The World Health Organisation (WHO) has recommended the use of GlaxoSmithKline's malaria vaccine in chi...
October 7, 2021, 9:08 am
Oric pharmaceuticals presents initial clinical data from phase 1b trial of oric-101 in combination with enzalutamide and preclinical data on oric-114 at aacr-nci-eortc
ORIC-101 and enzalutamide combination regimen at the recommended Phase 2 dose was well tolerated; adver...
October 7, 2021, 8:55 am
Oric pharmaceuticals presents initial clinical data from phase 1b trial of oric-101 in combination with enzalutamide and preclinical data on oric-114 at aacr-nci-eortc
ORIC-101 and enzalutamide combination regimen at the recommended Phase 2 dose was well tolerated; adver...
October 7, 2021, 8:55 am